We are monitoring the impact of COVID-19 on U.S. eClinical Solutions Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11652
Share on
Share on

U.S. eClinical Solutions Market Research Report – Segmented By Product, Delivery Mode, Development Phase, End-User and Country – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11652
Pages: 100

U.S. eClinical Solutions Market Size (2021 to 2026)

The size of the U.S. eClinical Solutions Market is expected to grow significantly from 2021 to 2026.

The pharmaceutical and biotechnology industries’ increasing spending on clinical research and development, the number of clinical trials, the need for enhanced data standardization, the use of clinical trial outsourcing, and biopharmaceutical companies are increasing their spending to develop therapies for diseases such as diabetes, cancer, and AIDS, are all boosting the growth of the U.S. e-clinical solutions market. The rising prevalence of chronic and lifestyle-related diseases, as well as the growing geriatric population, are other factors propelling the U.S. e-clinical solutions market forward. As a result, the number of drugs in development is increasing, leading to an increase in clinical trials. The expanding usage of cloud technologies in the development of e-clinical suits and the expansion of clinical research in emerging nations offers potential for firms interested in investing in the e-clinical solutions market. Clinical trials are becoming more common in developed countries due to the large number of patients available, low operating costs, and higher recruitment rates. This provides key players with more opportunities.

Factors such as a long approval period for clinical trials, a shortage of broadband facilities and IT specialists in rural places, high implementation costs, and less-skilled labor have hindered the U.S. eClinical solutions market. For example, companies that install software on their own servers are responsible for the ongoing costs of electricity and server hardware. Furthermore, because vendors are constantly developing new upgrades to the product, software maintenance and up-gradation incur huge costs that will hinder market development. Increased competition, high drug development costs, a more restrictive regulatory environment, and a lack of awareness among researchers about the benefits of eClinical solutions could all slow the market's growth. In contrast, limited adoption of eClinical solutions in developed countries and patient privacy could pose a challenge.

Covid-19 Impact on the U.S. eClinical Solutions Market:

The COVID-19 pandemic has played an important role in the market for eClinical solutions. The majority of pharmaceutical and biotech businesses have devoted their R&D efforts to help develop a COVID-19 vaccine. eClinical solutions are a solution that integrates technology, goods, and services to conduct and automate clinical trials, allowing for improved data administration and the integration of various trial data for more efficient observation. Various companies are working on analytical software to manage COVID-19's impact on their ongoing trials. For example, based on industry and customer input, eClinical Solution, Inc. has launched “Elluminate COVID-19 Analytics” to assist sponsors in managing the impact of COVID-19 on their ongoing trials. U.S. eClinical solutions are projected to address this need and deliver high-quality healthcare to those living in distant areas. Furthermore, healthcare systems are overloaded due to the COVID-19 epidemic, and eClinical solutions are being used to give logistical help in the provision of critical services.

This research report on the U.S. eClinical Solutions market has been segmented & sub-segmented into the following categories:

By Product:

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platform
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trial Master Files (eTMF)
  • Regulatory Information Management Solutions (RIMS)
  • Others

By Delivery Mode:

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based

By Development Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End-User:

  • Hospitals
  • CROs
  • Academic institutes
  • Pharma & Biotech Organizations
  • Medical Device Manufacturers

By Country:

  • The United States

The United States had the most significant share in the global eClinical solutions market in 2020. With the increased prevalence of lifestyle-related ailments, including diabetes and heart disease, the growing target population is expected to propel the regional market for eClinical solutions forward. Furthermore, the presence of major competitors and the availability of advanced infrastructure, as the need for the effective administration of large and confidential data volumes grows, will eClinical solutions, which are expected to boost the regional market's growth. The market revenue will be accelerated further by the expanding clinical research activities in the United States and the rapid move from manual data explanation to real-time data analysis during clinical trials.

KEY MARKET PLAYERS:

Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc., Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and Eclinical Solutions, LLC are some of the noteworthy companies operating in the U.S. eClinical solutions market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Products and Services
      1. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
      2. Clinical Trial Management Systems (CTMS)
      3. Clinical Analytics Platform
      4. Randomization and Trial Supply Management (RTMS)
      5. Clinical Data Integration Platform
      6. Electronic Clinical Outcome Assessment (eCOA)
      7. Safety Solutions
      8. Electronic Trial Master Files (eTMF)
      9. Regulatory Information Management Solutions (RIMS)
      10. Others
      11. Y-o-Y Growth Analysis, By Products and Services
      12. Market Attractiveness Analysis, By Products and Services
      13. Market Share Analysis, By Products and Services
    2. By Delivery Mode
      1. Web-hosted (On-demand)
      2. Licensed Enterprise (On-premise)
      3. Cloud-based
      4. Y-o-Y Growth Analysis, By Delivery Mode
      5. Market Attractiveness Analysis, By Delivery Mode
      6. Market Share Analysis, By Delivery Mode
    3. By Development Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
      5. Y-o-Y Growth Analysis, By Development Phase
      6. Market Attractiveness Analysis, By Development Phase
      7. Market Share Analysis, By Development Phase
    4. By End Users
      1. Hospitals
      2. CROs
      3. Academic institutes
      4. Pharma & Biotech Organizations
      5. Medical Device Manufacturers
      6. Y-o-Y Growth Analysis, By End Users
      7. Market Attractiveness Analysis, By End Users
      8. Market Share Analysis, By End Users
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. The United States
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Oracle Corporation
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Medidata Solutions, Inc.
    3. Parexel International Corporation
    4. Bioclinica, Inc.
    5. Datatrak International, Inc.
    6. CRF Health
    7. ERT Clinical
    8. Merge Healthcare Incorporated
    9. Omnicomm Systems, Inc.
    10. Maxisit Inc.
    11. Bio-Optronics, Inc.
    12. Eclinical Solutions, LLC.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product, delivery mode, development phase, end-user, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. U.S. eClinical Solutions Market, By Product, From 2021 to 2026 (USD Million)
  2. U.S. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) Market, By Region, From 2021 to 2026 (USD Million)
  3. U.S. Clinical Trial Management Systems (CTMS) Market, By Region, From 2021 to 2026 (USD Million)
  4. U.S. Clinical Analytics Platform Market, By Region, From 2021 to 2026 (USD Million)
  5. U.S. Randomization and Trial Supply Management (RTMS) Market, By Region, From 2021 to 2026 (USD Million)
  6. U.S. Clinical Data Integration Platform Market, By Region, From 2021 to 2026 (USD Million)
  7. U.S. Electronic Clinical Outcome Assessment (eCOA) Market, By Region, From 2021 to 2026 (USD Million)
  8. U.S. Safety Solutions Market, By Region, From 2021 to 2026 (USD Million)
  9. U.S. Electronic Trial Master Files (eTMF) Market, By Region, From 2021 to 2026 (USD Million)
  10. U.S. Regulatory Information Management Solutions (RIMS) Market, By Region, From 2021 to 2026 (USD Million)
  11. U.S. Others Market, By Region, From 2021 to 2026 (USD Million)
  12. U.S. eClinical Solutions Market, By Delivery Mode, From 2021 to 2026 (USD Million)
  13. U.S. Web-hosted (On-demand) Market, By Region, From 2021 to 2026 (USD Million)
  14. U.S. Licensed Enterprise (On-premise) Market, By Region, From 2021 to 2026 (USD Million)
  15. U.S. Cloud-based Market, By Region, From 2021 to 2026 (USD Million)
  16. U.S. eClinical Solutions Market, By Development Phase, From 2021 to 2026 (USD Million)
  17. U.S. Phase I Market, By Region, From 2021 to 2026 (USD Million)
  18. U.S. Phase II Market, By Region, From 2021 to 2026 (USD Million)
  19. U.S. Phase III Market, By Region, From 2021 to 2026 (USD Million)
  20. U.S. Phase IV Market, By Region, From 2021 to 2026 (USD Million)
  21. U.S. eClinical Solutions Market, By End-User, From 2021 to 2026 (USD Million)
  22. U.S. Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  23. U.S. CROs Market, By Region, From 2021 to 2026 (USD Million)
  24. U.S. Academic institutes Market, By Region, From 2021 to 2026 (USD Million)
  25. U.S. Pharma & Biotech Organizations Market, By Region, From 2021 to 2026 (USD Million)
  26. U.S. Medical Device Manufacturers Market, By Region, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample